Hamide Barzegar: Exploring Maternal Substance Use Impact on Neonates
Hamide Barzegar, Neonatologist at Shiraz University of Medical Sciences, shared a post on LinkedIn about a paper published in BMC Pregnancy and Childbirth:
“Our new article has just been published in BMC Pregnancy and Childbirth:
‘Maternal substance use disorder and neonatal health: epidemiologic and socioeconomic determinants in a case-control study, Shiraz, Iran.’
In this case-control study, we explored how maternal substance use disorder and socioeconomic factors influence neonatal outcomes, including the length of hospital stay, need for treatment, Finnegan score, and discharge disposition.
One of the key findings was that socioeconomic and maternal educational status strongly affected neonatal health outcomes and discharge plans, highlighting the need for multidimensional care and social support for this vulnerable population.
Methadone was the most common substance used.
40% of infants were transferred to social services.
Higher maternal education was linked to longer hospitalization.
Socioeconomic factors played a significant role in outcomes.
I’d love to hear from you:
What has been your experience with neonatal abstinence syndrome or caring for infants born to mothers with substance use disorder?
Have you observed similar socioeconomic influences in your practice or research?”
Title: Maternal substance use disorder and neonatal health: epidemiologic and socioeconomic determinants in a case-control study, Shiraz, Iran
Authors: Roya Oboodi, Hamide Barzegar, Marziyeh Doostfatemeh, Reza Bahrami, Somayeh Zolfaghari, Alireza Salehi
Read the full paper.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 15, 2026, 08:18MHR Calls for Papers on Organoids, Assembloids and Emerging 3D Reproductive Models – ESHRE
-
Mar 15, 2026, 08:10This Month’s F and S On Air Podcast Episode Has Been Posted – Fertility and Sterility
-
Mar 15, 2026, 07:10Thomas McDonnel: Beta-2-Glycoprotein I Beyond Antibodies and APS
-
Mar 15, 2026, 06:52Fostamatinib as a Potential Treatment for APS-Related Thrombocytopenia – British Journal of Haematology
-
Mar 15, 2026, 06:49Does Endometrial Injury Improve Pregnancy Outcomes? – RBMO
-
Mar 15, 2026, 06:45Ultrasound Monitoring and Ovulation Trigger in IUI – Fertility and Sterility
-
Mar 15, 2026, 06:40Uterus Transplantation in Focus at Upcoming ESHRE Webinar – ESHRE
-
Mar 15, 2026, 06:34Abinet Gadissa: Patience Rewards the Scan in Fetal Echocardiography
-
Mar 15, 2026, 05:48RBMO Shares New Findings on Cell Number Biopsied During PGT-A